EOLS logo

Evolus (EOLS) Company Overview

Profile

Full Name:

Evolus, Inc.

Sector:

Healthcare

Country:

United States

IPO:

February 8, 2018

Indexes:

Not included

Description:

EOLS, a part of Evolus, focuses on providing innovative aesthetic products, particularly in the field of non-surgical beauty treatments. Their main product, Jeuveau, is a popular injectable treatment for reducing wrinkles, helping people enhance their appearance and boost confidence.

Key Details

Price

$14.03

Annual Revenue

$202.09 M(+35.98% YoY)

Annual EPS

-$1.08(+18.80% YoY)

Annual ROE

298.15%

Beta

1.02

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Mar 4, 2025

Recent annual earnings:

Mar 4, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 14, 25 HC Wainwright & Co.
Buy
Jan 27, 25 Barclays
Overweight
Jan 22, 25 HC Wainwright & Co.
Buy
Jan 21, 25 Needham
Buy
Nov 7, 24 HC Wainwright & Co.
Buy
Nov 1, 24 HC Wainwright & Co.
Buy
Oct 3, 24 HC Wainwright & Co.
Buy
Sep 16, 24 Cantor Fitzgerald
Overweight
Sep 13, 24 Needham
Buy
Sep 13, 24 Barclays
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Evolus?
  • Does Evolus pay dividends?
  • What sector is Evolus in?
  • What industry is Evolus in?
  • What country is Evolus based in?
  • When did Evolus go public?
  • Is Evolus in the S&P 500?
  • Is Evolus in the NASDAQ 100?
  • Is Evolus in the Dow Jones?
  • When was Evolus's last earnings report?
  • When does Evolus report earnings?
  • Should I buy Evolus stock now?

What is the ticker symbol for Evolus?

The ticker symbol for Evolus is NASDAQ:EOLS

Does Evolus pay dividends?

No, Evolus does not pay dividends

What sector is Evolus in?

Evolus is in the Healthcare sector

What industry is Evolus in?

What country is Evolus based in?

Evolus is headquartered in United States

When did Evolus go public?

Evolus's initial public offering (IPO) was on February 8, 2018

Is Evolus in the S&P 500?

No, Evolus is not included in the S&P 500 index

Is Evolus in the NASDAQ 100?

No, Evolus is not included in the NASDAQ 100 index

Is Evolus in the Dow Jones?

No, Evolus is not included in the Dow Jones index

When was Evolus's last earnings report?

Evolus's most recent earnings report was on Mar 4, 2025

When does Evolus report earnings?

The date for Evolus's next earnings report has not been announced yet

Should I buy Evolus stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions